The Global Cardiac Assist Devices Market Size is projected to grow at a CAGR of 13.70% during the forecast period from 2026 to 2034 | DelveInsight

The Cardiac Assist Devices market was valued at USD 3.29 billion in 2025 and is projected to reach USD 10.44 billion by 2034.

DelveInsight's Cardiac Assist Devices Market Insights Report 2034 provides the current and forecast market analysis, individual leading Cardiac Assist Devices companies' market shares, challenges, Cardiac Assist Devices Market Drivers, barriers, trends, and key market Cardiac Assist Devices companies in the market.

To read more about the latest highlights related to the Cardiac Assist Devices Market @ https://www.delveinsight.com/report-store/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Cardiac Assist Devices Market Report

- In July 2025, CorWave SA announced the first implantation in the world of its novel Left Ventricular Assist System based on wave membrane technology, a biomimetic architecture that restores physiological pulsatility, distinguishing it from continuous-flow rotary pumps. Strategic significance: Validates an entirely new pump architecture and positions CorWave at the frontier of an innovation cycle focused on physiological flow.
- In April 2025, European regulators approved a new fully implantable left ventricular assist device, enhancing long-term, portable support for patients with advanced heart failure by removing the percutaneous driveline. Strategic significance: Addresses driveline infection, the principal source of morbidity in durable mechanical circulatory support, and establishes a new competitive standard for the durable segment.
- The global Cardiac Assist Devices market is expected to expand at a CAGR of 13.70% during the forecast period from 2026 to 2034.
- By product, ventricular assist devices dominated with a 62% share in 2025. By type, implantable devices led with a 61% share. By therapy, destination therapy led with a 47% share, and by end-user, hospitals accounted for 68% share.
- North America accounted for the largest share at 45% in 2025, while Asia-Pacific is anticipated to register the fastest growth through 2034.
- The principal drivers are the rising burden of cardiovascular disease; the scarcity of heart donors; technological innovation and miniaturization; aging populations and rising life expectancy; a shift toward minimally invasive and percutaneous implantation techniques; and enhanced reimbursement and improving healthcare infrastructure.
- The leading Cardiac Assist Devices Companies include Abbott Laboratories, Abiomed Inc., Teleflex Incorporated, Getinge AB, Medtronic plc, SynCardia Systems LLC, CARMAT SA, Berlin Heart GmbH, CorWave SA, and BiVACOR Inc., among others.

To know more about why North America is leading the market growth in the Cardiac Assist Devices Market, Get a snapshot @ https://www.delveinsight.com/report-store/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Cardiac Assist Devices Overview

Cardiac assist devices are mechanical circulatory support systems that partially or completely take over the pumping function of a failing heart, sustaining systemic perfusion in patients whose native cardiac output is inadequate. The category comprises ventricular assist devices, which support one or both ventricles; total artificial hearts, which replace both native ventricles and valves outright in patients with irreversible biventricular failure; and intra-aortic balloon pumps, which provide counterpulsation support and remain the most widely used temporary circulatory support device.

These devices are deployed across three therapeutic intents: bridge-to-transplant, bridge-to-candidacy, and destination therapy, which provides permanent support for patients ineligible for transplantation. Contemporary innovation centers on full implantability and wireless energy transfer, magnetically levitated pumps that reduce thrombosis, miniaturized percutaneous systems, and the integration of artificial intelligence for flow optimization and remote monitoring.

Cardiac Assist Devices Market Key Growth Drivers

- The rising burden of cardiovascular disease, with the British Heart Foundation reporting that 620 million people, or one in thirteen individuals, live with heart and circulatory diseases globally, is generating an expanding pool of candidates for mechanical circulatory support.
- The scarcity of heart donors is the single most distinctive driver of this market, with the Health Resources and Services Administration reporting 3,436 patients on the United States heart transplant waiting list in 2024 and 17 deaths each day among those awaiting an organ.
- Technological innovation and miniaturization, including smaller implantable left ventricular assist devices, percutaneous pumps, and improved biocompatible materials, are expanding clinical eligibility and improving outcomes.
- Aging populations and rising life expectancy are enlarging the geriatric segment most prone to cardiovascular complications and end-stage heart failure.
- A shift toward minimally invasive and percutaneous implantation techniques is reducing recovery time and broadening the eligible patient population.
- Enhanced reimbursement, improving healthcare infrastructure in emerging markets, and integration of remote monitoring, telemedicine, and artificial intelligence for flow optimization and predictive analytics are increasing access and adoption.

Get a sneak peek at the Cardiac Assist Devices Market Dynamics @ https://www.delveinsight.com/report-store/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Cardiac Assist Devices Market Segment Analysis

The Cardiac Assist Devices market is segmented by Product (Ventricular Assist Devices [Left Ventricular Assist Devices, Biventricular Assist Devices, and Right Ventricular Assist Devices], Total Artificial Hearts, and Intra-Aortic Balloon Pumps), Type (Transcutaneous and Implantable), Therapy (Bridge-to-Transplant, Bridge-to-Candidacy, and Destination Therapy), End-User (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of World).

Ventricular assist devices led the product segment with a 62% share in 2025, with left ventricular assist devices holding the leading position given their pivotal role in managing severe heart failure and their increasing use as destination therapy for patients who are not transplant candidates. By type, implantable devices held a 61% share, as durable ventricular assist devices and total artificial hearts command prices well above temporary transcutaneous systems and only implantable architectures can sustain a patient for the years that destination therapy requires. By therapy, destination therapy led with a 47% share, reflecting the structural repositioning of mechanical support from a temporary bridge toward a definitive long-term therapy. By end-user, hospitals accounted for 68% share, given the specialized implanting infrastructure and multidisciplinary care these procedures require.

Which cardiac support key players in the Cardiac Assist Devices Market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Cardiac Assist Devices Market Competitive Landscape

The Cardiac Assist Devices market is classified as Consolidated. A small number of large medical technology companies control the commercial durable and percutaneous support franchises: Abbott Laboratories leads durable ventricular assist devices, Abiomed Inc. leads percutaneous mechanical circulatory support, and Teleflex Incorporated and Getinge AB lead intra-aortic balloon pumps, with SynCardia Systems LLC, CARMAT SA, and Berlin Heart GmbH holding specialized positions. Barriers to entry are exceptionally high, reflecting the premarket approval pathway required for these highest-risk device classes, the cost and duration of pivotal clinical evidence, and the manufacturing precision required for implantable blood pumps.

Cardiac Assist Devices Companies

Abbott Laboratories, Abiomed Inc., Teleflex Incorporated, Getinge AB, Medtronic plc, SynCardia Systems LLC, CARMAT SA, Berlin Heart GmbH, CorWave SA, BiVACOR Inc., and others.

Cardiac Assist Devices Market Restraints

Despite a compelling clinical rationale and a structurally expanding patient population, the Cardiac Assist Devices market faces material constraints. Device-related complication risk is the most significant, with driveline infection remaining the principal source of morbidity in durable support, and pump thrombosis and thromboembolic events persisting despite magnetic levitation and improved hemocompatible surfaces. Cost is a second constraint, as the total episode encompassing implantation, prolonged intensive care, and lifelong follow-up places the therapy among the costliest in cardiovascular medicine, limiting adoption where reimbursement is unfavorable. Stringent regulatory requirements for these highest-risk device classes lengthen development timelines, while limited implanting capacity and trained multidisciplinary teams constrain volume in many regions. The imposition of import tariffs on medical devices and components has further increased costs and disrupted supply chains, prompting strategic shifts in manufacturing and sourcing.

Interested in knowing the Cardiac Assist Devices Market by 2034? Click to get a snapshot of the Cardiac Assist Devices Market Trends -https://www.delveinsight.com/report-store/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Cardiac Assist Devices Market Report

- Coverage- Global
- Forecast Period- 2026-2034
- Cardiac Assist Devices Companies- Abbott Laboratories, Abiomed Inc., Teleflex Incorporated, Getinge AB, Medtronic plc, SynCardia Systems LLC, CARMAT SA, Berlin Heart GmbH, CorWave SA, BiVACOR Inc., and others.
- Cardiac Assist Devices Market Restraints and Regulatory Analysis
- Cardiac Assist Devices Porter Five Forces Analysis and Market Assessment

Explore more information on the Cardiac Assist Devices Market Insights @ https://www.delveinsight.com/report-store/cardiac-assist-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

1. Introduction
2. Executive Summary of Cardiac Assist Devices Market
3. Key Factors Impacting the Cardiac Assist Devices Market
4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
5. Regulatory Analysis
6. Porter's Five Forces Analysis
7. Cardiac Assist Devices Market Assessment
8. Cardiac Assist Devices Market Competitive Landscape
9. Cardiac Assist Devices Market Startup Funding and Investment Trends
10. Cardiac Assist Devices Market Company and Product Profiles
11. KOL Views
12. Project Approach
13. About DelveInsight
14. Disclaimer and Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.